Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shenxiang qiangxin decoction
- Development stage
- Unknown
- Lead developer
- Central Hospital of Shanghai Putuo District
- Administration
- Oral
01
Overview
Shenxiang Qiangxin Decoction is a traditional Chinese medicine (TCM) herbal formula developed by Putuo District Central Hospital in Shanghai. It is specifically formulated for the treatment of heart failure, particularly in patients exhibiting heart-kidney Yang deficiency syndrome according to TCM diagnostic criteria. The decoction aims to improve cardiac performance and alleviate clinical symptoms by tonifying Yang and strengthening the heart. It is currently being investigated in clinical trials to establish its efficacy and safety profile as a therapeutic intervention for chronic heart failure.
- Other names
- Shenxiang Qiangxin YinShenxiang Qiangxin Tang
Beyond the preview
Go deeper on shenxiang qiangxin decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shenxiang qiangxin decoction.